In the future it will be common practice to use stem cell products to treat illnesses in the same way we use medications today

Pipeline

  • Adipose-derived stem cell (ADSC) secreted factors: cosmetic products
  • ADSC for the treatment of Multiple Sclerosis (MS)
  • Anti-BMP small molecules for the treatment of MS
  • Genetically modified muscle progenitor cells (MPCs) that secrete neurotropic factors (NTFs)
    • MPC-NTFs: peripheral nerve injury
    • MPC-NTFs: neuropathic pain
  • Mesenchymal stem cell derived vesicles – exosomes secreted from cells for the treatment of autistic disorders (NOFAR program, Israel)
  • Production and Supply of Finolim (Fingolimod, Gilenia™)